Paradigm Capital Management Inc. NY reduced its stake in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 62.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 150,000 shares of the company's stock after selling 250,000 shares during the period. Paradigm Capital Management Inc. NY owned approximately 0.39% of Viemed Healthcare worth $1,203,000 at the end of the most recent reporting period.
Several other hedge funds also recently added to or reduced their stakes in the stock. Divisadero Street Capital Management LP increased its position in shares of Viemed Healthcare by 84.8% during the fourth quarter. Divisadero Street Capital Management LP now owns 646,273 shares of the company's stock worth $5,183,000 after acquiring an additional 296,481 shares during the last quarter. Renaissance Technologies LLC grew its stake in Viemed Healthcare by 2.3% during the 4th quarter. Renaissance Technologies LLC now owns 373,000 shares of the company's stock valued at $2,991,000 after purchasing an additional 8,400 shares in the last quarter. Bard Associates Inc. increased its holdings in Viemed Healthcare by 1.3% during the 4th quarter. Bard Associates Inc. now owns 349,526 shares of the company's stock worth $2,803,000 after purchasing an additional 4,474 shares during the last quarter. First Eagle Investment Management LLC raised its position in shares of Viemed Healthcare by 196.5% in the 4th quarter. First Eagle Investment Management LLC now owns 328,824 shares of the company's stock valued at $2,637,000 after purchasing an additional 217,923 shares in the last quarter. Finally, Northern Trust Corp boosted its stake in shares of Viemed Healthcare by 1.8% during the 4th quarter. Northern Trust Corp now owns 286,818 shares of the company's stock valued at $2,300,000 after buying an additional 5,090 shares during the last quarter. 74.24% of the stock is owned by hedge funds and other institutional investors.
Viemed Healthcare Stock Down 0.1%
VMD stock opened at $6.75 on Tuesday. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03. The firm has a 50 day simple moving average of $6.97 and a 200-day simple moving average of $7.81. The company has a market capitalization of $266.79 million, a P/E ratio of 25.00 and a beta of 1.49. Viemed Healthcare, Inc. has a twelve month low of $6.14 and a twelve month high of $9.81.
Viemed Healthcare (NASDAQ:VMD - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.06 EPS for the quarter, meeting analysts' consensus estimates of $0.06. The firm had revenue of $59.10 million for the quarter, compared to the consensus estimate of $60.60 million. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%.
About Viemed Healthcare
(
Free Report)
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Further Reading
Want to see what other hedge funds are holding VMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Viemed Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.
While Viemed Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.